Last reviewed · How we verify

NCT06371131

Effect of Stellate Ganglion Block on Postoperative Nausea and Vomiting

Status unknown NA Last updated 26 April 2024
What this trial tests

NA trial testing Right -stellate ganglion block in Stellate Ganglion Block in 200 participants. Status unknown.

Timeline
17 April 2023
Primary endpoint
30 May 2024
30 August 2024

Quick facts

Lead sponsorThe Second Affiliated Hospital of Chongqing Medical University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposehealth services research
Enrollment200
Start date17 April 2023
Primary completion30 May 2024
Estimated completion30 August 2024
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

The Second Affiliated Hospital of Chongqing Medical University

Who can join

Adults 18 to 70, any sex, with Stellate Ganglion Block or Thyroid Surgery. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Postoperative nausea and vomiting is one of the most common postoperative complications second only to postoperative pain. Studies have reported that without any antiemetic prevention treatment, the overall incidence of PONV in surgical operations is up to 20-30%, and the incidence of PONV in high-risk patients such as thyroid surgery is even up to 70-80%. PONV not only increased discomfort and prolonged hospital stay; Severe cases can lead to wound dehysis, acid-base imbalance, water and electrolyte metabolism disorders, seriously affect the prognosis of patients. Although various prevention and treatment measures have been adopted in clinical practice, it still cannot be completely eliminated. Therefore, postoperative nausea and vomiting of thyroid is still a concern in clinical anesthesia work, so it is urgent to explore more simple and effective measures to prevent thyroid PONV. SGB is the injection of local anesthetics into loose connective tissue containing stellate ganglion. It has a clear effect on postoperative analgesia of thyroid surgery, and can play a certain role in preventing thyroid PONV by reducing the application of perioperative opioids. Few studies have reported that the incidence of PONV can be significantly reduced after the application of SGB in patients with thyroid surgery, which provides a certain basis for the prevention of thyroid PONV. Therefore, this study aims to explore the effect of right stellate ganglion block on preventing postoperative nausea and vomiting of thyroid, and to explore the possible mechanism of action.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Stellate Ganglion Block

Currently open trials in the same condition.

Other The Second Affiliated Hospital of Chongqing Medical University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06371131.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing